BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 30639450)

  • 1. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study.
    Kouvari M; Panagiotakos DB; Yannakoulia M; Georgousopoulou E; Critselis E; Chrysohoou C; Tousoulis D; Pitsavos C;
    Metabolism; 2019 Apr; 93():18-24. PubMed ID: 30639450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.
    Kouvari M; Chrysohoou C; Skoumas J; Pitsavos C; Panagiotakos DB; Mantzoros CS;
    Metabolism; 2022 Mar; 128():154893. PubMed ID: 34600906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.
    Gao M; Lv J; Yu C; Guo Y; Bian Z; Yang R; Du H; Yang L; Chen Y; Li Z; Zhang X; Chen J; Qi L; Chen Z; Huang T; Li L;
    PLoS Med; 2020 Oct; 17(10):e1003351. PubMed ID: 33125374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes.
    Park YM; Steck SE; Fung TT; Zhang J; Hazlett LJ; Han K; Merchant AT
    Int J Obes (Lond); 2016 Oct; 40(10):1541-1549. PubMed ID: 27339604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolically healthy obese phenotype and risk of cardiovascular disease: Results from the China Health and Retirement Longitudinal Study.
    Li H; He D; Zheng D; Amsalu E; Wang A; Tao L; Guo J; Li X; Wang W; Guo X
    Arch Gerontol Geriatr; 2019; 82():1-7. PubMed ID: 30710843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk.
    Mongraw-Chaffin M; Foster MC; Anderson CAM; Burke GL; Haq N; Kalyani RR; Ouyang P; Sibley CT; Tracy R; Woodward M; Vaidya D
    J Am Coll Cardiol; 2018 May; 71(17):1857-1865. PubMed ID: 29699611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
    Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Cardiovascular Diseases Among Different Metabolic Obesity Phenotypes: A Prospective Observational Study.
    Liu X; Yang C; Dang Y; Chang Z; Li J; Zhao Y; Zhang Y
    Metab Syndr Relat Disord; 2023 Aug; 21(6):306-313. PubMed ID: 37590875
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
    Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
    Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population.
    Dhana K; Koolhaas CM; van Rossum EF; Ikram MA; Hofman A; Kavousi M; Franco OH
    PLoS One; 2016; 11(4):e0154273. PubMed ID: 27100779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition of metabolic phenotypes and risk of subclinical atherosclerosis according to BMI: a prospective study.
    Lin L; Zhang J; Jiang L; Du R; Hu C; Lu J; Wang T; Li M; Zhao Z; Xu Y; Xu M; Bi Y; Ning G; Wang W; Chen Y
    Diabetologia; 2020 Jul; 63(7):1312-1323. PubMed ID: 32130460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall Cohort Study.
    Kowall B; Lehmann N; Mahabadi AA; Moebus S; Erbel R; Jöckel KH; Stang A
    Nutr Metab Cardiovasc Dis; 2019 Mar; 29(3):228-235. PubMed ID: 30648599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically healthy obesity and the risk for subclinical atherosclerosis.
    Kim TJ; Shin HY; Chang Y; Kang M; Jee J; Choi YH; Ahn HS; Ahn SH; Son HJ; Ryu S
    Atherosclerosis; 2017 Jul; 262():191-197. PubMed ID: 28385392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Health, Obesity, and the Risk of Developing Open-Angle Glaucoma: Metabolically Healthy Obese Patients versus Metabolically Unhealthy but Normal Weight Patients.
    Jung Y; Han K; Park HYL; Lee SH; Park CK
    Diabetes Metab J; 2020 Jun; 44(3):414-425. PubMed ID: 31950773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Metabolic Health and Obesity on Subclinical Target Organ Damage.
    Lee HJ; Kim HL; Chung J; Lim WH; Seo JB; Kim SH; Zo JH; Kim MA
    Metab Syndr Relat Disord; 2018 Feb; 16(1):46-53. PubMed ID: 29319402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.